Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 7;35(11):178.
doi: 10.1007/s11274-019-2739-1.

Metabolomic Studies of Pseudomonas Aeruginosa

Free PMC article

Metabolomic Studies of Pseudomonas Aeruginosa

Karolina Anna Mielko et al. World J Microbiol Biotechnol. .
Free PMC article


Pseudomonas aeruginosa is a common, Gram-negative environmental organism. It can be a significant pathogenic factor of severe infections in humans, especially in cystic fibrosis patients. Due to its natural resistance to antibiotics and the ability to form biofilms, infection with this pathogen can cause severe therapeutic problems. In recent years, metabolomic studies of P. aeruginosa have been performed. Therefore, in this review, we discussed recent achievements in the use of metabolomics methods in bacterial identification, differentiation, the interconnection between genome and metabolome, the influence of external factors on the bacterial metabolome and identification of new metabolites produced by P. aeruginosa. All of these studies may provide valuable information about metabolic pathways leading to an understanding of the adaptations of bacterial strains to a host environment, which can lead to new drug development and/or elaboration of new treatment and diagnostics strategies for Pseudomonas.

Keywords: Cystic fibrosis; Metabolomic experiment; Metabolomics; Pseudomonas aeruginosa; Strain identification.

Conflict of interest statement

All authors declare that they have no conflict of interest.


Fig. 1
Fig. 1
Metabolomic studies of Pseudomonas aeruginosa
Fig. 2
Fig. 2
Diagram of metabolomic experiment

Similar articles

See all similar articles


    1. Bail S, Buchbauer G, Jirovetz L, Denkova Z, Slavchev A, Stoyanova A, Geissler M. Antimicrobial activities of roman chamomile oil from france and its main compounds. J Essent Oil Res. 2009;21(3):283–286. doi: 10.1080/10412905.2009.9700171. - DOI
    1. Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context. 2018;7:1–18. doi: 10.7573/dic.212527. - DOI - PMC - PubMed
    1. Behrends V, Ryall B, Zlosnik JEA, Speert DP, Bundy JG, Williams HD. Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections. Environ Microbiol. 2013;15(2):398–408. doi: 10.1111/j.1462-2920.2012.02840.x. - DOI - PubMed
    1. Behrends V, Williams HD, Bundy JG. Metabolic footprinting: extracellular metabolomic analysis. Methods Mol Biol. 2014;1149:281–292. doi: 10.1007/978-1-4939-0473-0_230. - DOI - PubMed
    1. Bendiak G, Ratjen F. The approach to Pseudomonas aeruginosa in cystic fibrosis. Semin Respir Crit Care Med. 2009;30:587–595. doi: 10.1055/s-0029-1238917. - DOI - PubMed

MeSH terms

LinkOut - more resources